Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ГБУЗ «Городская клиническая больница им. С.С. Юдина» Департамента здравоохранения г. Москвы, Москва, Россия npkrotenko@gmail.com
Список исп. литературыСкрыть список 1. Reintam A, Parm P, Kitus R et al. Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiol Scand 2009; 53 (3): 318–24. DOI: 10.1111/j.1399-6576.2008.01.860.x. PMID: 19243317. 2. Docsa T et al. The Role of Inflammatory Mediators in the Development of Gastrointestinal Motility Disorders. Int J Mol Sci 2022; 23 (13): 6917. 3. Heyland D et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. J Parenter Enter Nutr 2003; 27 (5): 355–73. 4. Dive A et al. Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 2000; 26 (7): 901–7. 5. Retief I. The management of motility disorders in critical illness. South Afr J Clin Nutr 2011; 24 (Sup. 3): 15–8. 6. Ukleja A. Altered GI Motility in Critically Ill Patients: Current Understanding of Pathophysiology, Clinical Impact, and Diagnostic Approach. Nutr Clin Pract 2010; 25 (1): 16–25. 7. Алексеева Е.В. Прокинетики в лечении синдрома кишечной недостаточности у хирургических больных в критическом состоянии. Автореф. дисс. … на соискание ученой степени канд. мед. наук. М., 2010. Alekseeva E.V. Prokinetics in the treatment of intestinal insufficiency syndrome in critical surgical patients. Autoref. diss. ... for the degree of Candidate of medical Sciences. Moscow, 2010 (in Russian). 8. Peng R et al. The efficacy and safety of prokinetics in critically ill adults receiving gastric feeding tubes: A systematic review and meta-analysis. Ed. L.S. Wieland. Plos One 2021; 16 (1): e0245317. 9. Nguyen NQ. Pharmacological therapy of feed intolerance in the critically ills. World J Gastrointest Pharmacol Ther 2014; 5 (3): 148. 10. Chapman MJ et al. Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance. J Parenter Enter Nutr 2021; 45 (1): 115–24. 11. McClave SA et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). J Parenter Enter Nutr 2016; 40 (2): 159–211. 12. Nguyen NQ et al. Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance. Intensive Care Med 2008; 34 (1): 169–73. 13. Arunachala Murthy T et al. Gastrointestinal dysfunction during enteral nutrition delivery in intensive care unit (ICU) patients: Risk factors, natural history, and clinical implications. A post-hoc analysis of The Augmented versus Routine approach to Giving Energy Trial (TARGET). Am J Clin Nutr 2022; 116 (2): 589–98. 14. Koopman N et al. The Multifaceted Role of Serotonin in Intestinal Homeostasis. Int J Mol Sci 2021; 22 (17): 9487. 15. Шур В.Ю., Самотруева М.А., Мажитова М.В. и др. Серотонин: биологические свойства и перспективы клинического применения. Фундаментальные исследования. 2014; 7 (часть 3): 621–9. Shur V.Yu., Samotrueva M.A., Mazhitova M.V. et al. Serotonin: biological properties and prospects for clinical use. Fundamental research. 2014; 7 (chast' 3): 621–9 (in Russian). 16. Gaginella TS, Galligan JJ. Serotonin and gastrointestinal function. 1st ed. Ed. T.S. Gaginella, J.J. Galligan. CRC Press, 2020. 17. Aikiyo S et al. Contribution of Serotonin 3A Receptor to Motor Function and Its Expression in the Gastrointestinal Tract. Digestion 2021; 102 (4): 516–26. 18. Taniyama K et al. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine 4 receptor, in gastrointestinal motility. J Gastroenterol 2000; 35 (8): 575–82. 19. De Ponti F. Pharmacology of serotonin: what a clinician should know. Gut 2004; 53 (10): 1520. 20. Соловьев И.А., Колунов А.В. Послеоперационный парез кишечника – проблема абдоминальной хирургии. Вестник Национального медико-хирургического центра им. Н.И. Пирогова. 2013. C. 112–18. Solov'ev I.A., Kolunov A.V. Postoperative intestinal paresis is a problem of abdominal surgery. Bulletin of the National Medical and Surgical Center named after N.I. Pirogov. 2013. P. 112–18 (in Russian). 21. Лазаренко В.А. и др. Влияние серотонина адипината на функциональные взаимоотношения компонентов гастродуоденального комплекса в условиях экспериментального моделирования интраабдоминальной гипертензии. Курский научно-практический вестник «Человек и его здоровье». 2015; 2: 79–84. Lazarenko V.A. et al. The effect of serotonin adipinate on the functional relationships of the components of the gastroduodenal complex in the conditions of experimental modeling of intraabdominal hypertension. Kursk scientific and practical bulletin "Man and his health". 2015; 2: 79–84 (in Russian). 22. Тропская Н.С., Соловьева Г.И., Порядков Л.Ф. Влияние серотонина адипината на электрическую активность желудка и тонкой кишки в раннем послеоперационном периоде. Тезисный доклад. М., 2003. C. 116. Tropskaya N.S., Solov'eva G.I., Poryadkov L.F. The effect of serotonin adipinate on the electrical activity of the stomach and small intestine in the early postoperative period. Thesis report. Moscow, 2003. P. 116 (in Russian). 23. Singer P et al. Trauma Acute Care Surg. Clin Nutr 2019; 38 (1): 48–79. 24. Bugaev N et al. J Trauma Acute Care Surg 2019; 87 (4): 922–34. 25. Nguyen NQ et al. Prokinetic therapy for feed intolerance in critical illness: One drug or two? Crit Care Med 2007; 35 (11): 2561–7. 26. MacLaren R et al. Erythromycin vs Metoclopramide for Facilitating Gastric Emptying and Tolerance to Intragastric Nutrition in Critically Ill Patients. J Parenter Enter Nutr 2008; 32 (4): 412–9. 27. Singh NK. Erythromycin as a prokinetic: Is the overall benefit corroborated? Crit Care Med 2007; 35 (5): 1446. 28. Gong J et al. Randomised clinical trial: prucalopride, a colonic pro-motility agent, reduces the duration of post-operative ileus after elective gastrointestinal surgery. Aliment Pharmacol Ther 2016; 43 (7): 778–89. 29. Milne T et al. Effect of prucalopride to improve time to gut function recovery following elective colorectal surgery: randomized clinical trial. Br J Surg 2022. P. znac121. 30. Reignier J et al. Erythromycin and early enteral nutrition in mechanically ventilated patients: Crit Care Med 2002; 30 (6): 1237–41. 31. Makkar J et al. Comparison of erythromycin versus metoclopramide for gastric feeding intolerance in patients with traumatic brain injury: A randomized double-blind study. Saudi J Anaesth 2016; 10 (3): 308. 32. Jandee S, Wetwittayakhlang P, Boonsri P. Efficacy of prucalopride in critically ill patients with paralytic ileus: A pilot randomized double-blind placebo-controlled trial. J Gastroenterol Hepatol 2021; 36 (2): 362–6. 33. Lewis K et al. The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials. Crit Care 2016; 20 (1): 259. 34. Maruna P, Fraško R, Gürlich R. Plasma procalcitonin in patients with ileus: relations to other inflammatory parameters. Physiol Res 2008: 481–6. 35. Schwarz NT et al. Pathogenesis of Paralytic Ileus: Intestinal Manipulation Opens a Transient Pathway Between the Intestinal Lumen and the Leukocytic Infiltrate of the Jejunal Muscularis. Ann Surg 2002; 235 (1). P. 31–40. 36. Liu L et al. Activation of p38 mitogen-activated protein kinase pathway by lipopolysaccharide aggravates postoperative ileus in colorectal cancer patients. J Gastroenterol Hepatol 2022; 37 (3): 518–30. 37. Lehrskov LL, Christensen RH. The role of interleukin-6 in glucose homeostasis and lipid metabolism. Semin Immunopathol 2019; 41 (4): 491–9. 38. Rana SV et al. Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients. J Crohns Colitis 2014; 8 (8): 859–65. 39. Fukaura K et al. Mucosally Expressed Cytokines are Associated with the Esophageal Motility Function. Digestion 2018; 98 (2): 95–103. 40. Stakenborg N et al. Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons. Gut 2019; 68 (8): 1406–16. 41. Серебряная Н.Б., Шанин С.Н., Фомичева Е.Е., Якуцени П.П. Тромбоциты как активаторы и регуляторы воспалительных и иммунных реакций. Часть 1. Основные характеристики тромбоцитов как воспалительных клеток. Медицинская иммунология. 2018;. 20 (6): 785–96. DOI: 10.15789/1563-0625-2018-6-785-796 Serebryanaya N.B., Shanin S.N., Fomicheva E.E., Yakutseni P.P. Blood platelets as activators and regulators of inflammatory and immune reactions. Part 1. Basic characteristics of platelets as inflammatory cells. Medical Immunology. 2018;. 20 (6): 785–96. DOI: 10.15789/1563-0625-2018-6-785-796 (in Russian).